Pharma Limited News Today

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 63,300 shares, a decline of 20.4% from the April 30th total of 79,500 shares. Based on an average daily volume of 69,800 shares, the short-interest ratio […]

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) was the target of a large drop in short interest in May. As of May 15th, there was short interest totalling 63,300 shares, a drop of 20.4% from the April 30th total of 79,500 shares. Based on an average daily volume of 69,800 shares, the days-to-cover ratio […]

Shares of OKYO Pharma Limited (LON:OKYO – Get Free Report) fell 24.3% on Thursday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 364,142 shares were traded during trading, a decline of 16% from the average session volume of 431,999 shares. The stock had previously closed at […]

Press Release Hyderabad, India, March 19, 2024 Aurobindo Pharma receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray ...

Firebrick Pharma Limited (AU:FRE) has released an update. Firebrick Pharma Limited has announced a change in the shareholding structure, with subst...

Firebrick Pharma Limited (AU:FRE) has released an update. Firebrick Pharma Limited has announced an application for the quotation of 16,000,000 new...

Firebrick Pharma Limited (AU:FRE) has released an update. Firebrick Pharma Limited has announced a change in the interests of substantial holder St...

Patent infringement occurs when someone uses, makes, sells, or imports a patented invention without the permission of the patent owner. It is a serious matter because it undermines the rights of...

LTR Pharma Limited (AU:LTP) has released an update. LTR Pharma Limited has addressed a price query from ASX Compliance, confirming no undisclosed i...

Firebrick Pharma Limited (AU:FRE) has released an update. Firebrick Pharma Limited has announced a new securities issue set for 31st May 2024, comp...